Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtrer
1.
Sci Adv ; 5(3): eaau0790, 2019 03.
Article de Anglais | MEDLINE | ID: mdl-30944850

RÉSUMÉ

Iron deficiency and anemia are prominent contributors to the preventable disease burden worldwide. A substantial proportion of people with inadequate dietary iron rely on rice as a staple food, but fortification efforts are limited by low iron bioavailability. Furthermore, using high iron fortification dosages may not always be prudent in tropical regions. To identify alternative fortification formulations with enhanced absorption, we screened different iron compounds for their suitability as rice fortificants, measured in vitro gastric solubility, and assessed dietary iron bioavailability using stable isotopic labels in rural Ghanaian children. Isotopic incorporation in red blood cells indicates that in the two age groups of children investigated (4 to 6 and 7 to 10 years), formulations provided 36 and 51% of the median daily requirement in absorbed iron, respectively. We describe approaches to enhancing iron bioavailability from fortified rice, which can substantially contribute to the prevention of iron deficiency in rice-eating populations.


Sujet(s)
Aliment enrichi , Fer alimentaire/administration et posologie , Micronutriments/administration et posologie , Oryza , Biodisponibilité , Taille/effets des médicaments et des substances chimiques , Poids/effets des médicaments et des substances chimiques , Enfant , Femelle , Ghana , Humains , Absorption intestinale , Fer alimentaire/métabolisme , Fer alimentaire/pharmacocinétique , Mâle , Micronutriments/métabolisme , Micronutriments/pharmacocinétique , Population rurale/statistiques et données numériques , Établissements scolaires/statistiques et données numériques
2.
Eur J Clin Nutr ; 71(1): 137-141, 2017 01.
Article de Anglais | MEDLINE | ID: mdl-27759065

RÉSUMÉ

BACKGROUND/OBJECTIVES: Fortifying cereal staples with zinc is a strategy for increasing zinc intake in young children in developing countries. However, phytic acid (PA) naturally present in cereals strongly decreases zinc absorption. A stable-isotope zinc absorption study was conducted in young children to investigate the ability of the PA-degrading enzyme phytase to improve zinc absorption, when added to a cereal porridge immediately before consumption. SUBJECTS/METHODS: Fractional absorption of zinc (FAZ) was estimated in 35 young healthy Burkinabe children using the double-isotopic tracer ratio method with 67Zn as oral tracer and 70Zn as intravenous tracer, in a crossover design. The test meals were: (a) a millet-based porridge containing 1.4 mg total zinc (native plus 1 mg added as ZnSO4) with a PA:Zn molar ratio of 7.7; (b) the same porridge with the enzyme phytase (20.5 phytase units (FTU)) added immediately before consumption. The exchangeable zinc pool (EZP) was determined as a potential measure of long-term zinc intake in 20 of the 35 children and compared with FAZ. RESULTS: Mean FAZ increased from 9.5±3.4 to 16.0±5.1% (P<0.0001), when phytase was added to the meal. The mean EZP was 3.6±0.5 mg/kg. There was no correlation between the EZP and FAZ values for either of the two test meals. CONCLUSIONS: Adding phytase immediately prior to consumption of a zinc-fortified cereal-based complementary food can improve zinc absorption in young children.


Sujet(s)
Phytase/administration et posologie , Consommation alimentaire , Grains comestibles/composition chimique , Aliment enrichi/analyse , Oligoéléments/pharmacocinétique , Zinc/pharmacocinétique , Biodisponibilité , Burkina , Enfant d'âge préscolaire , Femelle , Volontaires sains , Humains , Nourrisson , Mâle , Millets
3.
Eur J Clin Nutr ; 65(1): 20-5, 2011 Jan.
Article de Anglais | MEDLINE | ID: mdl-20842166

RÉSUMÉ

BACKGROUND/OBJECTIVES: Ferrous fumarate is recommended for the fortification of complementary foods based on similar iron absorption to ferrous sulfate in adults. Two recent studies in young children have reported that it is only 30% as well absorbed as ferrous sulfate. The objective of this study was to compare iron absorption from ferrous fumarate and ferrous sulfate in infants, young children and mothers. SUBJECTS/METHODS: Non-anemic Mexican infants (6-24 months), young children (2-5 years) and adult women were randomly assigned to receive either 4 mg Fe (women) or 2.5 mg Fe (infants and young children) as either [(57)Fe]-ferrous fumarate or [(58)Fe]-ferrous sulfate added to a sweetened drink based on degermed maize flour and milk powder. Iron absorption was calculated based on incorporation of isotopes into erythrocytes after 14 days. RESULTS: Within each population group, no significant differences (P > 0.05) in iron absorption were found between ferrous fumarate and ferrous sulfate. Mean iron absorption from ferrous fumarate vs ferrous sulfate was 17.5 vs 20.5% in women (relative bioavailability (RBV) =86), 7.0 vs 7.2% in infants (RBV = 97) and 6.3 vs 5.9% in young children (RBV = 106). CONCLUSIONS: Ferrous fumarate is as well absorbed as ferrous sulfate in non-anemic, iron sufficient infants and young children, and can be recommended as a useful fortification compound for complementary foods designed to prevent iron deficiency. Further studies are needed to clarify its usefulness in foods designed to treat iron deficiency.


Sujet(s)
Produits laitiers , Composés du fer II/administration et posologie , Aliment enrichi , Zea mays/métabolisme , Adulte , Anémie par carence en fer/prévention et contrôle , Boissons , Biodisponibilité , Enfant d'âge préscolaire , Évaluation de médicament , Femelle , Composés du fer II/pharmacocinétique , Composés du fer II/pharmacologie , Farine , Humains , Nourrisson , Absorption intestinale , Fer/sang , Fer alimentaire/administration et posologie , Fer alimentaire/pharmacocinétique , Modèles linéaires , Mexique , Édulcorants
4.
Int J Obes (Lond) ; 32(7): 1098-104, 2008 Jul.
Article de Anglais | MEDLINE | ID: mdl-18427564

RÉSUMÉ

BACKGROUND: Overweight is increasing in transition countries, while iron deficiency remains common. In industrialized countries, greater adiposity increases risk of iron deficiency. Higher hepcidin levels in obesity may reduce dietary iron absorption. Therefore, we investigated the association between body mass index (BMI) and iron absorption, iron status and the response to iron fortification in populations from three transition countries (Thailand, Morocco and India). METHODS: In Thai women (n=92), we examined the relationship between BMI and iron absorption from a reference meal containing approximately 4 mg of isotopically labeled fortification iron. We analyzed data from baseline (n=1688) and intervention (n=727) studies in children in Morocco and India to look for associations between BMI Z-scores and baseline hemoglobin, serum ferritin and transferrin receptor, whole blood zinc protoporphyrin and body iron stores, and changes in these measures after provision of iron. RESULTS: In the Thai women, 20% were iron deficient and 22% were overweight. Independent of iron status, a higher BMI Z-score was associated with decreased iron absorption (P=0.030). In the Indian and Moroccan children, 42% were iron deficient and 6.3% were overweight. A higher BMI Z-score predicted poorer iron status at baseline (P<0.001) and less improvement in iron status during the interventions (P<0.001). CONCLUSIONS: Adiposity in young women predicts lower iron absorption, and pediatric adiposity predicts iron deficiency and a reduced response to iron fortification. These data suggest the current surge in overweight in transition countries may impair efforts to control iron deficiency in these target groups. Interactions of the 'double burden' of malnutrition during the nutrition transition may have adverse consequences.


Sujet(s)
Adiposité , Anémie par carence en fer/métabolisme , Pays en voie de développement , Fer/métabolisme , Adolescent , Adulte , Marqueurs biologiques/sang , Indice de masse corporelle , Enfant , Femelle , Ferritines/sang , Aliment enrichi , Enquêtes de santé , Hémoglobines/analyse , Humains , Inde , Absorption intestinale , Troubles du métabolisme du fer/sang , Fer alimentaire/administration et posologie , Marquage isotopique , Mâle , Adulte d'âge moyen , Maroc , Analyse multifactorielle , Protoporphyrines/analyse , Récepteurs à la transferrine/sang , Thaïlande
5.
Eur J Clin Nutr ; 59(5): 668-74, 2005 May.
Article de Anglais | MEDLINE | ID: mdl-15756294

RÉSUMÉ

OBJECTIVES: (a) To measure iron absorption by human subjects from citric acid stabilized fish sauce fortified with ferrous sulfate, ferric ammonium citrate or ferrous lactate and (b) to identify the effect of added citric acid (3 g/l) on iron absorption from ferrous sulfate fortified fish sauce. DESIGN: Iron absorption from the intrinsically labeled compounds was determined via erythrocyte incorporation of isotopic labels ((57)Fe and (58)Fe) using a randomized crossover design. In three separate absorption studies, 10 adult women each consumed a basic test meal of rice and vegetable soup seasoned with isotopically labeled, iron fortified fish sauce. RESULTS: Iron absorption was significantly lower from ferrous lactate and from ferric ammonium citrate fortified fish sauce than from ferrous sulfate fortified fish sauce. Fractional iron absorption (geometric mean; -1s.d., +1s.d.) was 8.7(3.6; 21.4)% for ferrous lactate compared to 13.0(5.4; 31.4)% from ferrous sulfate, P = 0.003 (study 1) and 6.0(2.5; 14.3)% from ferric ammonium citrate relative to 11.7(4.4; 30.7)% from ferrous sulfate, P < 0.001, in study 2. Citric acid added at a molar ratio of approximately 2.5 to iron had no effect on iron absorption from ferrous sulfate (study 3). Iron absorption in the presence of citric acid was 14.1(6.4; 30.8)% compared to 12.0(5.8; 24.7)% in its absence (P = 0.26). CONCLUSIONS: Iron absorption was 50-100% higher from ferrous sulphate fortified fish sauce than from fish sauce fortified with ferric ammonium citrate or ferrous lactate. In the presence of citric acid as a chelator, ferrous sulfate would appear to be a useful fortificant for fish sauce. SPONSORSHIP: International Atomic Energy Agency (IAEA), Vienna, Austria.


Sujet(s)
Produits de la pêche , Aliment enrichi , Fer alimentaire/pharmacocinétique , Adolescent , Adulte , Acide citrique/administration et posologie , Acide citrique/pharmacologie , Études croisées , Femelle , Composés du fer III/administration et posologie , Composés du fer III/sang , Composés du fer III/pharmacocinétique , Composés du fer II/administration et posologie , Composés du fer II/sang , Composés du fer II/pharmacocinétique , Humains , Isotopes du fer/administration et posologie , Isotopes du fer/sang , Isotopes du fer/pharmacocinétique , Fer alimentaire/administration et posologie , Fer alimentaire/sang , Lactates/administration et posologie , Lactates/sang , Lactates/pharmacocinétique , Composés d'ammonium quaternaire/administration et posologie , Composés d'ammonium quaternaire/sang , Composés d'ammonium quaternaire/pharmacocinétique , Valeurs de référence
6.
Br J Nutr ; 84(2): 139-41, 2000 Aug.
Article de Anglais | MEDLINE | ID: mdl-11029963

RÉSUMÉ

In areas where iodized salt is not available, oral iodized oil is often used to correct I deficiency despite a lack of consensus on the optimal dose or duration of effect, particularly in children, a main target group. Annual doses ranging from 400 to 1000 mg have been advocated for school-age children. Because lower doses of iodized oil have been shown to be effective in treating I deficiency in adults, the aim of this study was to evaluate the efficacy and safety of a low dose of oral iodized oil in goitrous I-deficient children. Goitrous children (n 104, mean age 8.4 years, range 6-12 years, 47% female) received 0.4 ml oral iodized poppyseed-oil containing 200 mg I. Baseline measurements included I in spot urines (UI), serum thyroxine (T4), whole blood thyroid-stimulating hormone (TSH), and thyroid-gland volume using ultrasound. At 1, 5, 10, 15, 30 and 50 weeks post-intervention, UI, TSH and T4 were measured. At 10, 15, 30 and 50 weeks, thyroid-gland volume was remeasured. At 30 and 50 weeks the mean percentage change in thyroid volume from baseline was -35% and -41% respectively. The goitre rate fell to 38% at 30 weeks and 17% at 50 weeks. No child showed signs of I-induced hypo- or hyperthyroidism. UI remained significantly increased above baseline for the entire year (P < 0.001); the median UI at 50 weeks was 97 micrograms/l, at the World Health Organization cut-off value (100 micrograms/l) for I-deficiency disorders risk. In this group of goitrous children, an oral dose of 200 mg I as Lipiodol (Guerbert, Roissy CdG Cedex, France) was safe and effective for treating goitre and maintaining normal I status for at least 1 year.


Sujet(s)
Goitre endémique/traitement médicamenteux , Iode/déficit , Huile iodée/administration et posologie , Enfant , Femelle , Humains , Iode/sang , Iode/urine , Mâle , Glande thyroide/imagerie diagnostique , Résultat thérapeutique , Échographie
7.
Eur J Endocrinol ; 142(3): 217-23, 2000 Mar.
Article de Anglais | MEDLINE | ID: mdl-10700714

RÉSUMÉ

OBJECTIVE: In developing countries, many children are at high risk for both goiter and iron-deficiency anemia. Because iron deficiency may impair thyroid metabolism, the aim of this study was to determine if iron supplementation improves the response to oral iodine in goitrous, iron-deficient anemic children. DESIGN: A trial of oral iodized oil followed by oral iron supplementation in an area of endemic goiter in the western Ivory Coast. METHODS: Goitrous, iodine-deficient children (aged 6-12 years; n=109) were divided into two groups: Group 1 consisted of goitrous children who were not anemic; Group 2 consisted of goitrous children who were iron-deficient anemic. Both groups were given 200mg oral iodine as iodized oil. Thyroid gland volume using ultrasound, urinary iodine concentration (UI), serum thyroxine (T(4)) and whole blood TSH were measured at baseline, and at 1, 5, 10, 15 and 30 weeks post intervention. Beginning at 30 weeks, the anemic group was given 60mg oral iron as ferrous sulfate four times/week for 12 weeks. At 50 and 65 weeks after oral iodine (8 and 23 weeks after completing iron supplementation), UI, TSH, T(4) and thyroid volume were remeasured. RESULTS: The prevalence of goiter at 30 weeks after oral iodine in Groups 1 and 2 was 12% and 64% respectively. Mean percent change in thyroid volume compared with baseline at 30 weeks in Groups 1 and 2 was -45.1% and -21.8% respectively (P<0.001 between groups). After iron supplementation in Group 2, there was a further decrease in mean thyroid volume from baseline in the anemic children (-34.8% and -38.4% at 50 and 65 weeks) and goiter prevalence fell to 31% and 20% at 50 and 65 weeks. CONCLUSION: Iron supplementation may improve the efficacy of oral iodized oil in goitrous children with iron-deficiency anemia.


Sujet(s)
Anémie par carence en fer/complications , Anémie par carence en fer/traitement médicamenteux , Compléments alimentaires , Goitre endémique/complications , Goitre endémique/traitement médicamenteux , Huile iodée/usage thérapeutique , Fer/administration et posologie , Hormones thyroïdiennes/métabolisme , Administration par voie orale , Anémie par carence en fer/métabolisme , Enfant , Côte d'Ivoire , Femelle , Goitre endémique/métabolisme , Humains , Mâle , Glande thyroide/imagerie diagnostique , Glande thyroide/effets des médicaments et des substances chimiques , Facteurs temps , Résultat thérapeutique , Échographie
8.
Eur J Clin Nutr ; 54(3): 209-13, 2000 Mar.
Article de Anglais | MEDLINE | ID: mdl-10713742

RÉSUMÉ

OBJECTIVES: To determine the efficacy of oral iodized oil in goitrous children who are both selenium (Se) and iodine deficient; to investigate if Se status modifies the response of iodine deficient, goitrous children to oral supplementation with iodized oil. DESIGN: A longitudinal intervention trial. SETTING: Two rural villages in the western Côte d'Ivoire. SUBJECTS: 51 goitrous non-anemic schoolchildren with both iodine and Se deficiency. INTERVENTION: Each child received an oral dose of 0.4 ml iodized poppyseed oil containing 200 mg of iodine. They were followed for 1 y with measurements of urinary iodine (UI), thyrotropin (TSH), thyroxine (T4), and thyroid volume by ultrasound. RESULTS: At baseline all children were goitrous and Se deficient; median UI was 29 microg/l and mean serum Se (s.d.) was 14.8 (10.7) microg/l. After receiving iodized oil, thyroid volume decreased significantly vs baseline at 10, 15, 30 and 50 weeks (P<0.001). At 50 weeks mean percentage change in thyroid volume from baseline was-46.6% and only five children remained goitrous. Median TSH values at 5, 10, 15, 30 and 50 weeks were reduced significantly (P<0.001) compared to baseline. Among individual children the severity of Se deficiency predicted the degree of response to iodized oil. Baseline serum Se and percentage change in thyroid volume from baseline at 50 weeks were strongly correlated (r2=0.554). Baseline Se and percentage decrease in TSH from baseline at 30 weeks were also well-correlated (r2=0.467). CONCLUSION: Although more severe Se deficiency partially blunts the thyroid response to iodine supplementation, oral iodized oil is an effective method for iodine repletion in goitrous children who are Se deficient. SPONSORSHIP: The Swiss Federal Institute of Technology, Zürich, the Foundation for Micronutrients in Medicine, Rapperswil, Switzerland, and the Thrasher Research Fund, Salt Lake City, USA.


Sujet(s)
Goitre/traitement médicamenteux , Iode/déficit , Huile iodée/administration et posologie , Sélénium/déficit , Glande thyroide/imagerie diagnostique , Hormones thyroïdiennes/sang , Indice de masse corporelle , Enfant , Côte d'Ivoire , Femelle , Goitre/sang , Goitre/imagerie diagnostique , Humains , Huile iodée/usage thérapeutique , Études longitudinales , Mâle , Analyse de régression , Population rurale , Sélénium/sang , Thyréostimuline/sang , Thyroxine/sang , Échographie
9.
Am J Clin Nutr ; 71(1): 88-93, 2000 Jan.
Article de Anglais | MEDLINE | ID: mdl-10617951

RÉSUMÉ

BACKGROUND: In developing countries, many children are at high risk of goiter and iron deficiency anemia. Because iron deficiency can have adverse effects on thyroid metabolism, iron deficiency may influence the response to supplemental iodine in areas of endemic goiter. OBJECTIVE: The aim of this study was to determine whether goitrous children with iron deficiency anemia would respond to oral iodine supplementation. DESIGN: A trial of oral iodine supplementation was carried out in an area of endemic goiter in western Côte d'Ivoire in goitrous children (n = 109) aged 6-12 y. Group 1 (n = 53) consisted of goitrous children who were not anemic. Group 2 (n = 56) consisted of goitrous children who had iron deficiency anemia. At baseline, thyroid gland volume and urinary iodine, thyrotropin, and thyroxine were measured by using ultrasound. Each child received 200 mg I orally and was observed for 30 wk, during which urinary iodine, thyrotropin, thyroxine, hemoglobin, and thyroid gland volume were measured. RESULTS: The prevalence of goiter at 30 wk was 12% in group 1 and 64% in group 2. The mean percentage change from baseline in thyroid volume 30 wk after administration of oral iodine was -45.1% in group 1 and -21.8% in group 2 (P < 0.001). Among the anemic children, there was a strong correlation between the percentage decrease in thyroid volume and hemoglobin concentration (r(2) = 0.65). CONCLUSION: The therapeutic response to oral iodine was impaired in goitrous children with iron deficiency anemia, suggesting that the presence of iron deficiency anemia in children limits the effectiveness of iodine intervention programs.


Sujet(s)
Anémie par carence en fer/complications , Goitre endémique/traitement médicamenteux , Huile iodée/usage thérapeutique , Administration par voie orale , Enfant , Côte d'Ivoire/épidémiologie , Femelle , Goitre endémique/complications , Goitre endémique/épidémiologie , Humains , Iode/urine , Huile iodée/administration et posologie , Mâle , Prévalence , Thyréostimuline/sang , Thyroxine/sang
10.
Schweiz Med Wochenschr ; 128(20): 770-4, 1998 May 16.
Article de Anglais | MEDLINE | ID: mdl-9642752

RÉSUMÉ

To prevent iodine deficiency disorders in Switzerland, table salt is currently fortified at 15 mg iodide/kg salt. However, several recent reports have suggested that urinary iodine excretion is marginal or inadequate among segments of the Swiss population, including schoolchildren. There is concern that iodine intake in Switzerland may be approaching levels associated with signs of clinical deficiency. Previous studies measuring urinary iodine in Swiss children have encompassed only a limited geographic area in central Switzerland. We have now evaluated urinary iodine concentrations in 243 schoolchildren aged 5 to 13 years from the Zurich area and the Engadine valley. The mean urinary iodine for all children was 11.3 +/- 8.7 micrograms/dl. There was no significant difference between iodine levels in urine from children in the Engadine and those from around Zurich. There were also no significant gender differences in urinary iodine concentrations. The median urinary iodine concentration for all children was 9.6 micrograms/dl, below the threshold suggested by the World Health Organization (< 10 micrograms/dl) as indicative of mild iodine deficiency. 54.3% of the children had urinary iodine concentrations < 10 micrograms/dl and 11.5% had levels < 5 micrograms/dl. The results of this study suggest that the iodine status of some Swiss schoolchildren may no longer be adequate. They indicate the importance of intermittent monitoring of iodine status in Switzerland, where dietary habits and food supply patterns are changing. They also support the recent decision (February 1998) by the Swiss Federal Department of the Interior to increase the concentration of iodide in Swiss table salt, based on the recommendations of the Fluoride-Iodine Commission of the Swiss Academy of Medical Sciences.


Sujet(s)
Goitre endémique/prévention et contrôle , Iode/urine , Dépistage de masse , Population rurale , Population urbaine , Adolescent , Enfant , Enfant d'âge préscolaire , Femelle , Goitre endémique/urine , Humains , Iode/administration et posologie , Iode/déficit , Mâle , Valeurs de référence , Facteurs de risque , Chlorure de sodium alimentaire/administration et posologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE